MRP ₹99
(Inclusive of all Taxes)
₹14.8 Cashback (15%)
Composition :
CLINDAMYCIN-1%W/V
Manufacturer/Marketer :
Rekvina Laboratories Ltd
Consume Type :
TOPICAL
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Caution
No interactions were found/established. Please consult your doctor if you have any concerns.
Pregnancy
Caution
Please consult your doctor before using Rakcen Topical Solution if you are pregnant or planning to conceive.
Breast Feeding
Caution
Please consult your doctor before using Rakcen Topical Solution if you are breastfeeding. If you need to apply the cream, gel or lotion on your breasts, don't do this shortly before giving a feed.
Driving
Safe if prescribed
Rakcen Topical Solution has no or negligible influence on the ability to drive or use machines.
Liver
Caution
Let your doctor know if you have any history of liver diseases before using Rakcen Topical Solution.
Kidney
Caution
Let your doctor know if you have any history of kidney diseases before using Rakcen Topical Solution.
Children
Unsafe
Rakcen Topical Solution is not recommended in children below 12 years of age.
Product Substitutes
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
CLINDAMYCIN-1%W/VOther bacterial intestinal infections
Severe
CLINDAMYCIN-1%W/VDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
Drug-Diseases Interactions
Login/Sign Up
CLINDAMYCIN-1%W/VOther bacterial intestinal infections
Severe
How does the disease interact with Rakcen Topical Solution:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
CLINDAMYCIN-1%W/VDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
How does the disease interact with Rakcen Topical Solution:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
CLINDAMYCIN-1%W/VOther diseases of liver
Moderate
How does the disease interact with Rakcen Topical Solution:
The liver is the primary site of Rakcen Topical Solution metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Rakcen Topical Solution and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Rakcen Topical Solution therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Rakcen Topical Solution is primarily metabolized by the liver. Therapy with Rakcen Topical Solution should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
The liver is the primary site of Rakcen Topical Solution metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Rakcen Topical Solution and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Rakcen Topical Solution therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Rakcen Topical Solution is primarily metabolized by the liver. Therapy with Rakcen Topical Solution should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/VOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Rakcen Topical Solution:
Rakcen Topical Solution is partially removed by the kidney. Rakcen Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Rakcen Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Rakcen Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Rakcen Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Rakcen Topical Solution is partially removed by the kidney. Rakcen Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Rakcen Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Rakcen Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Rakcen Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/VOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Rakcen Topical Solution:
Rakcen Topical Solution is partially removed by the kidney. Rakcen Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Rakcen Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Rakcen Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Rakcen Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Rakcen Topical Solution is partially removed by the kidney. Rakcen Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Rakcen Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Rakcen Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Rakcen Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
All Substitutes & Brand Comparisons
RX
Out of StockClindaily Topical Solution
₹295
(₹2.66/ 1ml)
10% CHEAPERRX
Acnesol Solution 25 ml
Systopic Laboratories Pvt Ltd
₹116
(₹4.18/ 1ml)
40% COSTLIERRX
Clinmiskin Solution 30 ml
Torrent Pharmaceuticals Ltd
₹196
(₹5.88/ 1ml)
97% COSTLIER
Have a query?